Your browser doesn't support javascript.
loading
Skin sensitization in silico protocol.
Johnson, Candice; Ahlberg, Ernst; Anger, Lennart T; Beilke, Lisa; Benigni, Romualdo; Bercu, Joel; Bobst, Sol; Bower, David; Brigo, Alessandro; Campbell, Sarah; Cronin, Mark T D; Crooks, Ian; Cross, Kevin P; Doktorova, Tatyana; Exner, Thomas; Faulkner, David; Fearon, Ian M; Fehr, Markus; Gad, Shayne C; Gervais, Véronique; Giddings, Amanda; Glowienke, Susanne; Hardy, Barry; Hasselgren, Catrin; Hillegass, Jedd; Jolly, Robert; Krupp, Eckart; Lomnitski, Liat; Magby, Jason; Mestres, Jordi; Milchak, Lawrence; Miller, Scott; Muster, Wolfgang; Neilson, Louise; Parakhia, Rahul; Parenty, Alexis; Parris, Patricia; Paulino, Alexandre; Paulino, Ana Theresa; Roberts, David W; Schlecker, Harald; Stidl, Reinhard; Suarez-Rodrigez, Diana; Szabo, David T; Tice, Raymond R; Urbisch, Daniel; Vuorinen, Anna; Wall, Brian; Weiler, Thibaud; White, Angela T.
Afiliação
  • Johnson C; Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: cjohnson@leadscope.com.
  • Ahlberg E; Bioinformatics Department, The University of Uppsala, 752 36, Uppsala, Sweden.
  • Anger LT; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Beilke L; Toxicology Solutions Inc., San Diego, CA, USA.
  • Benigni R; Alpha-PreTox, Via G.Pascoli 1, 00184, Roma, Italy.
  • Bercu J; Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
  • Bobst S; Toxsci Advisors LLC, 2016 Main Suite 1901, Houston, TX, USA.
  • Bower D; Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
  • Brigo A; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
  • Campbell S; Nelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.
  • Cronin MTD; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.
  • Crooks I; British American Tobacco, Research and Development, Regents Park Road, Southampton, Hampshire, SO15 8TL, UK.
  • Cross KP; Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
  • Doktorova T; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
  • Exner T; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
  • Faulkner D; Chemical Sciences Division, Lawrence Berkeley National Lab, USA.
  • Fearon IM; whatIF? Consulting Ltd, The Crispin Burr Street, Harwell, OX11 0DT, UK.
  • Fehr M; DSM Nutritional Products, Kaiseraugst, Switzerland.
  • Gad SC; Gad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC, 27609, USA.
  • Gervais V; Servier Group, 905 Route de Saran, 45520, Gidy, France.
  • Giddings A; GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
  • Glowienke S; Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.
  • Hardy B; Edelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
  • Hasselgren C; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Hillegass J; Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.
  • Jolly R; Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.
  • Krupp E; Sanofi, Corporate HSE, Global Product Steweardship, Industriepark Hoechst, D-65926, Frankfurt Am Main, Germany.
  • Lomnitski L; Perrigo Israel Pharmaceuticals Ltd, Shoham, Israel.
  • Magby J; Colgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.
  • Mestres J; IMIM Hospital Del Mar Institute of Medical Research and University Pompeu Fabra, Doctor Aiguader 88, Parc de Recerca Biomèdica, 08003 Barcelona, Spain; and Chemotargets SL, Baldiri Reixac 4, Parc Científic de Barcelona, 08028, Barcelona, Spain.
  • Milchak L; 3M Company, St. Paul, MN, USA.
  • Miller S; Leadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
  • Muster W; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
  • Neilson L; Broughton Nicotine Services, Oak Tree House, West Craven Drive, Earby, Lancashire, BB18 6JZ, UK.
  • Parakhia R; Church & Dwight Co., Inc, 469 North Harrison Street, Princeton, NJ, 08543, USA.
  • Parenty A; Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.
  • Parris P; Pfizer Worldwide Research and Development, Sandwich, UK.
  • Paulino A; ORO AGRI Europe, S.A, Palmela, Portugal.
  • Paulino AT; ORO AGRI Europe, S.A, Palmela, Portugal.
  • Roberts DW; Nelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.
  • Schlecker H; Bayer AG, Research & Development, Pharmaceuticals, Industrial Chemicals Toxicology & Genetic Toxicology, 42096, Wuppertal, Germany.
  • Stidl R; Safetree Consulting e.U, Vienna, Austria.
  • Suarez-Rodrigez D; FStox Consulting LTD, 2 Brooks Road, Raunds, Wellingborough, NN9 6NS, UK.
  • Szabo DT; PPG Industries, Pittsburgh, PA, 15146, USA.
  • Tice RR; RTice Consulting, Hillsborough, NC, 27278, USA.
  • Urbisch D; BASF SE, Product Safety, Carl-Bosch-Strasse 38, 67056, Ludwigshafen Am Rhein, Germany.
  • Vuorinen A; DSM Nutritional Products, Kaiseraugst, Switzerland.
  • Wall B; Colgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.
  • Weiler T; Servier Group, 905 Route de Saran, 45520, Gidy, France.
  • White AT; GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
Regul Toxicol Pharmacol ; 116: 104688, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32621976
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Alérgenos / Medição de Risco / Haptenos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Alérgenos / Medição de Risco / Haptenos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article